() chairman Neil Ritson talks to Proactive about the firm’s decision to further increase its stake in the soon-to-produce Kiliwani North project, onshore Tanzania.
The firm bought an additional 3.825% stake in the venture from , increasing its interest to 10% from 6.125% but Ritson says that Solo still has cash to invest elsewhere.
He adds that the Tanzanian authorities have asked the firm to be ready to start the well next week, which, he says they will be.
Meet Advanced Oncotherapy, VolitionRx, Scancell Holdings Plc, Faron Pharmaceuticals Oy and Highlands Natural Resources Plc at our event,
London, 26 January 2017.
Register here »